How Long Should the Elderly Take Antidepressants?

Of 219 elderly patients with a major depressive disorder (meeting RDC), 69 recovered sufficiently and consented to enter a two-year double-blind placebo-controlled trial of dothiepin. Survival analysis revealed that dothiepin reduced the relative risk of relapse by two and a half times. Past but not...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of psychiatry 1993-02, Vol.162 (2), p.175-182
Hauptverfasser: Jacoby, Robin, Lunn, A. Daniel, Ardern, M., Bergmann, K., Conway, J., Cooling, N., Davies, G., Fisk, J., Gehlhaar, E., Harrison-Read, P., Hawley, R., Jacoby, R., Jones, R., Levy, R., MacDonald, A., Naguib, M., Oppenheimer, C., Philpot, M., Philpott, R., Pitt, B., Price, M., Robinson, J., Silverman, M., Simons, R., Slattery, Z., Staley, C., Taws, E., Tym, E., White, M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Of 219 elderly patients with a major depressive disorder (meeting RDC), 69 recovered sufficiently and consented to enter a two-year double-blind placebo-controlled trial of dothiepin. Survival analysis revealed that dothiepin reduced the relative risk of relapse by two and a half times. Past but not current serious physical illness was also associated with a favourable outcome, whereas a prolonged index depressive illness trebled the relative risk of relapse. In the light of previous research on prognosis it is suggested that elderly persons who recover from a major depressive illness should continue with antidepressant medication for at least two years, if not indefinitely.
ISSN:0007-1250
1472-1465
DOI:10.1192/bjp.162.2.175